Quarterly report [Sections 13 or 15(d)]

SCHEDULE OF RECONCILIATION OF ADJUSTED EBITDA (Details)

v3.25.2
SCHEDULE OF RECONCILIATION OF ADJUSTED EBITDA (Details) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Segment Reporting [Abstract]        
(Loss) income from continuing operations (GAAP Basis) $ (533,000) $ 2,511,000 $ 1,221,000 $ 3,323,000
Depreciation and amortization 101,000 67,000 196,000 119,000
Stock-based compensation 9,000 53,000 24,000 132,000
Severance & related expense 524,000 692,000
Asset impairment - lab supplies 198,000 198,000
Taxes expense 4,000 18,000 8,000
Interest accretion expense 12,000 30,000
Note payable interest 49,000 176,000 127,000 373,000
Other expense/income, net 10,000 (14,000) 14,000 (29,000)
Change in fair value of note payable 7,000 (57,000) (18,000) 41,000
Adjusted EBITDA $ 365,000 $ 2,752,000 $ 2,472,000 $ 3,997,000